Vineet Laboratories Ltd
Incorporated in 2003, Vineet Laboratories Ltd is in designing, developing, manufacturing of API Intermediates and Bulk Drugs
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Sales |
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Sales |
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit |
Ratios
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Export Revenue as % of Total Revenue % ・Standalone data |
|
||||
| Permanent Employees on Roll count ・Standalone data |
|||||
| Related Party Sales as % of Total Revenue % ・Standalone data |
|||||
| Number of Production Batches count ・Standalone data |
|||||
| Number of Products Manufactured count ・Standalone data |
|||||
| Total Dispatched Volume kg ・Standalone data |
|||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Approval Of Unaudited Finanicial Results For The Quarter Ended 30.09.2026
- Board meeting on 12 Nov 2026 to consider Q2/H1 FY2027 unaudited results and limited review report.
-
Appointment Of Internal Auditor Of The Company
- Vineet Laboratories appointed M/s. Krishna Reddy & Co. as Internal Auditor for FY2026-27.
-
Resignation Of Internal Auditor Of The Company
- M/s. V D P & Co resigned as internal auditor on 04 November 2026.
-
Appointment Of Cost Auditor Of The Company
- Board appoints M/s Mannidi & Associates as cost auditor for FY 2026-27.
-
Appointment Of Secretarial Auditor Of The Company
- Board approved appointment of Aakanksha Dubey & Co. as Secretarial Auditor for FY2026-27 to FY2030-31.
Annual reports
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
Business Overview[1]
The Co. manufactures and distributes pharmaceuticals, bulk drugs, chemicals, and pesticides. The company also conducts R&D across the biotechnology, healthcare, and industrial sectors, specializing in the export and import of various chemical formulations.